On 1st April 2019, pregabalin was classified as a controlled…
On 1st April 2019, pregabalin was classified as a controlled drug. This reclassification presented a number of different challenges for prescribers and patients. a) Explain how the reclassification affected patients using the NHS Repeat Dispensing Scheme and suggest a solution. (2 marks) b) Explain how the change in classification affected prescribers who prescribe the drug privately. (1 mark) A 38-year-old epileptic patient who takes carbamazepine and pregabalin for epilepsy. She has been taking both medicines for a number of years and is stable on them, her last seizure being four years ago. The GP practice where she is registered issues her with a 56-day supply of each medicine on a prescription. c) How will the change in classification of pregabalin practically affect the patient? (2 marks)